πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8829204

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8828996

Morpholine-spirocyclic piperidine amides as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8829007

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8822451

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8822469

Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8822681

Azaindoles useful as inhibitors of janus kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8815866

Aminopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809335

Pyrazolopyrimidine kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8809353

Quinazolines useful as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802868

Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-flu

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802844

Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802700

Modulators of ATP-Binding Cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8796453

Processes and intermediates for producing azaindoles

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8796308

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8796312

Heteroaryl derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated Β· Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785444

Thiazoles and pyrazoles useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785476

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785640

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779197

Aryl amides useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779156

Analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779127

Processes for preparing substituted pyrimidines

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765957

Process for making modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765731

Benzimidazole analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8765751

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted